Cargando…

Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method

OBJECTIVE: Flurbiprofen 8.75 mg lozenge and spray are used for symptomatic relief of sore throat, with a rapid onset of analgesia suggesting a localized mechanism of action. Building on previous studies, this investigation aimed to use microautoradiography to visualize the depth penetration of radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Rob, Wevrett, Sean Robert, Edmunds, Suzanne, Brown, Marc, Kulasekaran, Anuradha, Adegoke, Oluwajoba, Farrah, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826073/
https://www.ncbi.nlm.nih.gov/pubmed/33500668
http://dx.doi.org/10.2147/CPAA.S284433
_version_ 1783640455270891520
author Turner, Rob
Wevrett, Sean Robert
Edmunds, Suzanne
Brown, Marc
Kulasekaran, Anuradha
Adegoke, Oluwajoba
Farrah, John
author_facet Turner, Rob
Wevrett, Sean Robert
Edmunds, Suzanne
Brown, Marc
Kulasekaran, Anuradha
Adegoke, Oluwajoba
Farrah, John
author_sort Turner, Rob
collection PubMed
description OBJECTIVE: Flurbiprofen 8.75 mg lozenge and spray are used for symptomatic relief of sore throat, with a rapid onset of analgesia suggesting a localized mechanism of action. Building on previous studies, this investigation aimed to use microautoradiography to visualize the depth penetration of radiolabeled flurbiprofen into human pharynx tissue using an ex vivo model. Quantification of flurbiprofen in the tissue was performed to provide a quantitative representation of flurbiprofen distribution through the tissue. METHODS: Cadaveric human pharynx tissue was mounted between the donor and receiver compartments of a Franz diffusion cell. After that 8.75 mg spray and dissolved lozenge formulations, containing radiolabeled flurbiprofen, were added to the donor compartment of a Franz diffusion cell. After incubation for one hour, the pharynx tissue was removed, processed, and sectioned both horizontally and vertically. The sections were placed within an imaging cassette to determine the penetration of radiolabeled flurbiprofen visually, before being solubilized to quantify the amount of flurbiprofen present in each section. RESULTS: In the horizontally sectioned samples, flurbiprofen was present in the top layers of all replicates and decreased in intensity throughout the tissue. Of the applied dose, 48.0–99.9% of flurbiprofen was detected in the top one-third of the pharynx tissue, closest to the dosing site, and 0–14.8% of flurbiprofen was detected within the deepest third of pharynx tissue, furthest from the dosing site. In the vertically sectioned tissue samples, radiolabeled flurbiprofen was found at a high intensity at the dosing site and reduced in intensity throughout the thickness of the tissue. Lateral penetration of flurbiprofen was also seen in tissue dosed with the spray. CONCLUSION: Our findings demonstrate that lozenge and spray formulations of flurbiprofen can penetrate throughout the layers of cadaveric human pharynx tissue in an ex vivo model, as visualized by microautoradiography.
format Online
Article
Text
id pubmed-7826073
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78260732021-01-25 Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method Turner, Rob Wevrett, Sean Robert Edmunds, Suzanne Brown, Marc Kulasekaran, Anuradha Adegoke, Oluwajoba Farrah, John Clin Pharmacol Original Research OBJECTIVE: Flurbiprofen 8.75 mg lozenge and spray are used for symptomatic relief of sore throat, with a rapid onset of analgesia suggesting a localized mechanism of action. Building on previous studies, this investigation aimed to use microautoradiography to visualize the depth penetration of radiolabeled flurbiprofen into human pharynx tissue using an ex vivo model. Quantification of flurbiprofen in the tissue was performed to provide a quantitative representation of flurbiprofen distribution through the tissue. METHODS: Cadaveric human pharynx tissue was mounted between the donor and receiver compartments of a Franz diffusion cell. After that 8.75 mg spray and dissolved lozenge formulations, containing radiolabeled flurbiprofen, were added to the donor compartment of a Franz diffusion cell. After incubation for one hour, the pharynx tissue was removed, processed, and sectioned both horizontally and vertically. The sections were placed within an imaging cassette to determine the penetration of radiolabeled flurbiprofen visually, before being solubilized to quantify the amount of flurbiprofen present in each section. RESULTS: In the horizontally sectioned samples, flurbiprofen was present in the top layers of all replicates and decreased in intensity throughout the tissue. Of the applied dose, 48.0–99.9% of flurbiprofen was detected in the top one-third of the pharynx tissue, closest to the dosing site, and 0–14.8% of flurbiprofen was detected within the deepest third of pharynx tissue, furthest from the dosing site. In the vertically sectioned tissue samples, radiolabeled flurbiprofen was found at a high intensity at the dosing site and reduced in intensity throughout the thickness of the tissue. Lateral penetration of flurbiprofen was also seen in tissue dosed with the spray. CONCLUSION: Our findings demonstrate that lozenge and spray formulations of flurbiprofen can penetrate throughout the layers of cadaveric human pharynx tissue in an ex vivo model, as visualized by microautoradiography. Dove 2021-01-19 /pmc/articles/PMC7826073/ /pubmed/33500668 http://dx.doi.org/10.2147/CPAA.S284433 Text en © 2021 Turner et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Turner, Rob
Wevrett, Sean Robert
Edmunds, Suzanne
Brown, Marc
Kulasekaran, Anuradha
Adegoke, Oluwajoba
Farrah, John
Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
title Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
title_full Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
title_fullStr Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
title_full_unstemmed Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
title_short Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
title_sort penetration of flurbiprofen from a locally applied sore throat lozenge and spray into cadaveric human pharynx tissue: a novel ex vivo model and microautoradiography method
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826073/
https://www.ncbi.nlm.nih.gov/pubmed/33500668
http://dx.doi.org/10.2147/CPAA.S284433
work_keys_str_mv AT turnerrob penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod
AT wevrettseanrobert penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod
AT edmundssuzanne penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod
AT brownmarc penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod
AT kulasekarananuradha penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod
AT adegokeoluwajoba penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod
AT farrahjohn penetrationofflurbiprofenfromalocallyappliedsorethroatlozengeandsprayintocadaverichumanpharynxtissueanovelexvivomodelandmicroautoradiographymethod